Efficacy of pegylated interferon plus ribavirin combination therapy for hepatitis C patients with normal ALT levels: a matched case-control study.

doi:10.1007/s00535-011-0455-1

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Efficacy of pegylated interferon plus ribavirin combination therapy for hepatitis C patients with normal ALT levels: a matched case-control study.

Journal of gastroenterology - 1 Nov 2011

Hiramatsu Naoki, Inoue Yuko, Oze Tsugiko, Kurashige Nao, Yakushijin Takayuki, Mochizuki Kiyoshi, Miyagi Takuya, Tatsumi Tomohide, Kiso Shinichi, Kanto Tatsuya, Kasahara Akinori, Takehara Tetsuo, Oshita Masahide, Mita Eiji, Hagiwara Hideki, Inui Yoshiaki, Katayama Kazuhiro, Tamura Shinji, Yoshihara Harumasa, Imai Yasuharu, Hayashi Norio

Abstract excerpt

BACKGROUND: The antiviral effect of pegylated interferon (Peg-IFN) plus ribavirin combination therapy in chronic hepatitis C (CHC) patients with normal alanine aminotransferase (ALT) levels (N-ALT) has been reported to be equivalent to that for patients with elevated ALT levels (E-ALT). However, the actual antiviral effect in N-ALT patients remains obscure because efficacy can be overestimated in patients with an...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alanine Transaminase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Therapy, Combination

Share to Hepatitis C, Chronic

Share to Interferon-alpha

Share to Interferon alpha-2

Share to Polyethylene Glycols

Share to Propensity Score

Share to Ribavirin

Source

Open in PubMed

Identifiers

PMID: 21858637
DOI: 10.1007/s00535-011-0455-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Efficacy of pegylated interferon plus ribavirin combination therapy for hepatitis C patients with normal ALT levels: a matched case-control study.PMID 21858637Read ↗

Rapid normalization of alanine aminotransferase predicts viral response during combined peginterferon and ribavirin treatment in chronic hepatitis C patients.Semantic proximity Read ↗

Effectiveness of triple therapy with direct-acting antivirals for hepatitis C genotype 1 infection: application of propensity score matching in a national HCV treatment registry.Semantic proximity Read ↗

Effect of prolonged administration of pegylated interferon/ribavirin therapy in genotypes 2a and 2b: propensity score-matched analysis.Semantic proximity Read ↗

From trials to a real hospital setting: effectiveness of pegylated interferon-alpha-2b/ribavirin combination therapy for naïve chronic hepatitis C patients.Semantic proximity Read ↗

Interferon-alpha therapy for individuals with normal serum alanine aminotransferase levels before treatment.Semantic proximity Read ↗

[Hepatitis C].Semantic proximity Read ↗

Antiviral treatment of chronic hepatitis C in clinical routine.Semantic proximity Read ↗

Randomized study of peginterferon-alpha2a plus ribavirin vs peginterferon-alpha2b plus ribavirin in chronic hepatitis C.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.